SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

08 Aug 2025 Evaluate
The company witnessed a 5.24% growth in the revenue at Rs. 1914.38 millions for the quarter ended June 2025 as compared to Rs. 1819.12 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -106.81 millions as compared to Net Loss of Rs. -136.79 millions of corresponding quarter ended June 2024Operating profit for the quarter ended June 2025 decreased to 83.70 millions as compared to 87.14 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1914.38 1819.12 5.24 1914.38 1819.12 5.24 8864.91 7732.62 14.64
Other Income 36.89 17.80 107.25 36.89 17.80 107.25 206.15 188.83 9.17
PBIDT 83.70 87.14 -3.95 83.70 87.14 -3.95 912.18 460.13 98.24
Interest 113.44 136.17 -16.69 113.44 136.17 -16.69 661.19 543.26 21.71
PBDT -29.74 -49.03 -39.34 -29.74 -49.03 -39.34 -709.03 -102.41 592.34
Depreciation 134.03 126.93 5.59 134.03 126.93 5.59 525.27 493.90 6.35
PBT -163.77 -175.96 -6.93 -163.77 -175.96 -6.93 -1234.30 -596.31 106.99
TAX -56.96 -39.17 45.42 -56.96 -39.17 45.42 -471.20 -82.43 471.64
Deferred Tax -56.96 -1.34 4150.75 -56.96 -1.34 4150.75 -487.80 -82.43 491.77
PAT -106.81 -136.79 -21.92 -106.81 -136.79 -21.92 -763.10 -513.88 48.50
Equity 187.92 167.50 12.19 187.92 167.50 12.19 187.92 167.47 12.21
PBIDTM(%) 4.37 4.79 -8.73 4.37 4.79 -8.73 10.29 5.95 72.92

Camlin Fine Sciences Share Price

131.85 4.88 (3.84%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×